Scarica l'app Stockscreener
36.53
1.27%
-0.47
Dopo l'orario di chiusura:
36.28
-0.25
-0.68%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CORT Giù?
Forum
Previsione
Corcept Therapeutics Inc Borsa (CORT) Ultime notizie
Is Corcept Therapeutics Incorporated stock positioned for long term growthJuly 2025 Rallies & Capital Protection Trading Alerts - ulpravda.ru
Insider Sell: William Guyer Sells 20,000 Shares of Corcept Thera - GuruFocus
Guyer, Corcept therapeutics officer, sells $703k in shares By Investing.com - Investing.com Canada
CORT ALERT: Levi & Korsinsky Investigates Corcept Therapeutics Incorporated for Possible Securities Fraud Violations - ACCESS Newswire
Is Corcept Therapeutics Incorporated stock in correction or buying zoneDip Buying & High Accuracy Investment Signals - ulpravda.ru
CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating Corcept Therapeutics ... - Bluefield Daily Telegraph
CORCEPT ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
Why Corcept Therapeutics Incorporated stock is a must watch in 2025 - ulpravda.ru
Published on: 2026-01-08 22:12:30 - ulpravda.ru
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics IncorporatedCORT - PR Newswire
CORT Investors Have Opportunity to Join Corcept Therapeutics Incorporated Fraud Investigation with the Schall Law Firm - Business Wire
Corcept Therapeutics Shares Plunge Over 50% Following FDA Complete Response Letter - Intellectia AI
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% – Hagens Berman - GlobeNewswire Inc.
Buybacks Report: Is Corcept Therapeutics Incorporated HTD stock among top earnings playsJuly 2025 Trade Ideas & Safe Swing Trade Setups - moha.gov.vn
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Corcept Therapeutics Incorporated (CORT) - TMX Newsfile
Fraud Investigation Opened: Levi & Korsinsky Investigates Corcept Therapeutics Incorporated (CORT) on Behalf of Shareholders - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept ... - Bluefield Daily Telegraph
Corcept Therapeutics Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50%Hagens Berman - Investing News Network
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - GlobeNewswire Inc.
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50%Hagens Berman - Finviz
Potential Securities Fraud: Levi & Korsinsky Investigates Corcept Therapeutics Incorporated (CORT) - ACCESS Newswire
CORT ACTIVE INVESTIGATION: Lost Money on Corcept Therapeutics Incorporated? Contact Levi & Korsinsky Now - ACCESS Newswire
CORCEPT THERAPEUTICS is Being Investigated for Potential Securities Law ViolationsContact Kaplan Fox & Kilsheimer LLP - NewMediaWire
Corcept Therapeutics Incorporated Investigated by Shareholder Rights AdvocatesInvestors Should Contact Levi & Korsinsky Regarding Potential Securities Law ViolationsCORT - ACCESS Newswire
Why Corcept (CORT) Stock Is Trading Lower Today - Finviz
Why Is Crinetics Pharma Stock Soaring Monday?Crinetics Pharmaceuticals (NASDAQ:CRNX) - Benzinga
Corcept Therapeutics (NASDAQ:CORT) Shares Down 6.9% Following Analyst Downgrade - MarketBeat
Corcept (CORT) Surges 9.8%: Is This an Indication of Further Gains? - Yahoo Finance
1 Healthcare Stock to Target This Week and 2 We Turn Down - Finviz
What is HC Wainwright's Estimate for CORT FY2030 Earnings? - MarketBeat
Why is CORT stock falling today? - MSN
Fraud Investigation: Levi & Korsinsky Investigates Corcept Therapeutics Incorporated (CORT) on Behalf of Shareholders - ACCESS Newswire
Why Is CORT Stock Falling Today? - Asianet Newsable
Kaplan Fox Reminds Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Potential Securities Law Violations - NewMediaWire
Synergy Asset Management LLC Raises Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Why Corcept Therapeutics plummeted by 50% today - MSN
US FDA declines to approve Corcept's drug for rare hormonal disorder - ETPharma.com
Levi & Korsinsky Investigates Corcept Therapeutics Incorporated (CORT) Over Potential Securities Fraud Allegations - ACCESS Newswire
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), FibroBiologics, Inc. (FBLG) and Corcept Therapeutics (CORT) - The Globe and Mail
Corcept Therapeutics (CORT) stock rebounds today after FDA setback — here’s what investors are watching next - ts2.tech
Corcept setback as relacorilant filing for hypercortisolism is rejected - The Pharma Letter
Corcept Tanks on FDA's CRL to Relacorilant NDA in Hypercortisolism - Finviz
FDA rejects relacorilant for Cushing’s-related high blood pressure - Cushing's Disease News
Corcept Therapeutics (NASDAQ:CORT) Trading Up 9.7%Here's What Happened - MarketBeat
The FDA Just Snubbed Corcept Therapeutics. Should You Buy the Dip in CORT Stock or Stay Far Away - Barchart.com
Kaplan Fox Alerts Investors of Corcept Therapeutics, Inc. (CORT) to an Investigation of Possible Securities Law Violations - FinancialContent
Implied Volatility Surging for Corcept Stock Options - Yahoo Finance
Canaccord Genuity Adjusts Price Target for Corcept Therapeutics (CORT) | CORT Stock News - GuruFocus
Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT) and Mind Medicine (MNMD) - The Globe and Mail
Ulta Beauty To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday - Benzinga
Corcept Therapeutics (NASDAQ:CORT) Given New $99.00 Price Target at Canaccord Genuity Group - MarketBeat
Corcept Therapeutics stock price target lowered to $90 at H.C. Wainwright - Investing.com Canada
Corcept Therapeutics stock price target cut by Canaccord on FDA setback - Investing.com Canada
Corcept Therapeutics (CORT) Faces FDA Setback, But Growth Potent - GuruFocus
HC Wainwright & Co. Lowers Price Target for Corcept Therapeutics (CORT) | CORT Stock News - GuruFocus
FDA rejects drug for hormone disorder - medwatch.com
Kaplan Fox Announces an Investigation Into Corcept Therapeutics, Inc. (CORT) for Potential Securities Law Violations - The National Law Review
Corcept Therapeutics stock tanks on FDA relacorilant setback — what happens next for CORT - ts2.tech
Corcept Therapeutics (CORT) stock sinks after FDA rebuff; relacorilant outlook resets - ts2.tech
A Risky Spot For Corcept Therapeutics (NASDAQ:CORT) - Seeking Alpha
What drives Corcept Therapeutics Incorporated stock priceTrading Psychology Tips & Build Wealth With Strategy - earlytimes.in
FDA says it needs additional evidence of effectiveness for Corcept relacorilant - Yahoo Finance
Stocks making big moves yesterday: FuelCell Energy, Corcept, and PacBio - Yahoo Finance
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):